Zenas BioPharma, Inc. (ZBIO)
NASDAQ: ZBIO · Real-Time Price · USD
19.39
+1.55 (8.69%)
May 20, 2026, 3:33 PM EDT - Market open
Zenas BioPharma Analyst Ratings
Total Analysts
8
Consensus Rating
Strong Buy
Price Target
$42.29
Upside
+118.10%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $44 | Strong Buy | Reiterates | $44 | +126.92% | May 15, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $21 → $22 | Hold | Maintains | $21 → $22 | +13.46% | May 14, 2026 |
| Citigroup | Citigroup | Strong Buy Maintains $43 → $41 | Strong Buy | Maintains | $43 → $41 | +111.45% | Mar 17, 2026 |
| Guggenheim | Guggenheim | Strong Buy Maintains $45 → $55 | Strong Buy | Maintains | $45 → $55 | +183.65% | Mar 17, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $19 → $21 | Hold | Maintains | $19 → $21 | +8.30% | Mar 17, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $44 | Strong Buy | Reiterates | $44 | +126.92% | Mar 17, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $44 | Strong Buy | Reiterates | $44 | +126.92% | Feb 10, 2026 |
| Morgan Stanley | Morgan Stanley | Buy → Hold Downgrades $37 → $19 | Buy → Hold | Downgrades | $37 → $19 | -2.01% | Jan 6, 2026 |
| Wedbush | Wedbush | Buy Reiterates $45 | Buy | Reiterates | $45 | +132.08% | Dec 22, 2025 |
| Evercore ISI Group | Evercore ISI Group | Buy Initiates $55 | Buy | Initiates | $55 | +183.65% | Nov 26, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $34 → $37 | Buy | Maintains | $34 → $37 | +90.82% | Nov 13, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $27 → $46 | Strong Buy | Maintains | $27 → $46 | +137.24% | Oct 28, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $31 → $34 | Buy | Maintains | $31 → $34 | +75.35% | Oct 28, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $30 → $44 | Strong Buy | Maintains | $30 → $44 | +126.92% | Oct 28, 2025 |
| Wedbush | Wedbush | Buy Maintains $35 → $40 | Buy | Maintains | $35 → $40 | +106.29% | Oct 9, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +54.72% | Oct 9, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.